Kiniksa Pharmaceuticals Ltd. Class A Stock News

A good medical stock can help diversify a portfolio. This particular name is testing a fresh entry as funds pile in.

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA ) Q2 2025 Earnings Call July 29, 2025 8:30 AM ET Company Participants Jonathan Kirshenbaum - Investor Relations Officer Mark A. Ragosa - Senior VP & CFO Ross Michael Moat - Executive VP & Chief Commercial Officer Sanj K.

– ARCALYST ® (rilonacept) Q2 2025 net product revenue of $156.8 million, representing 52% year-over-year growth – – ARCALYST 2025 expected net product revenue increased to $625 - $640 million – – KPL-387 Phase 2/3 clinical trial in recurrent pericarditis initiated; Phase 2 data expected in 2H 2026 – – Cash balance increased by $39.4 million in Q2 2025 to $307.8 million – – Conference call and w...

LONDON, July 24, 2025 (GLOBE NEWSWIRE) --  Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 financial results and recent portfolio execution.

Explore the exciting world of Kiniksa Pharmaceuticals (KNSA 0.99%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!

Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.

Kiniksa Pharmaceuticals has delivered strong share price performance this year thanks to a strong start to the year for Arcalyst. Medicare redesign with improved patient affordability has boosted Arcalyst's sales and 2025 outlook. I expect a beat-and-raise 2025 with Arcalyst net sales reaching or exceeding $620 million.

– KPL-387 Phase 2/3 trial on track to initiate in mid-2025; Phase 2 data expected in 2H 2026 – – KPL-387 Phase 1 single ascending dose data support profile for monthly dosing – – Presentation and webcast at Jefferies 2025 Global Healthcare Conference scheduled for 12:50 pm ET today–